US SB1681 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Engrossed on December 18 2020 - 50% progression, died in chamber
Action: 2020-12-18 - Held at the desk.
Text: Latest bill text (Engrossed) [PDF]

Summary

A bill to educate health care providers and the public on biosimilar biological products, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Advancing Education on Biosimilars Act of 2020

Sponsors


History

DateChamberAction
2020-12-18HouseHeld at the desk.
2020-12-18HouseReceived in the House.
2020-12-18SenateMessage on Senate action sent to the House.
2020-12-17SenatePassed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7643)
2020-12-17SenateS.Amdt.2716 Amendment SA 2716 agreed to in Senate by Unanimous Consent.
2020-12-17SenateS.Amdt.2716 Amendment SA 2716 proposed by Senator Braun for Senator Alexander. (consideration: CR S7643; text: CR S7643) In the nature of a substitute.
2020-12-17SenateMeasure laid before Senate by unanimous consent. (consideration: CR S7642-7643)
2020-12-17SenateSenate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
2019-05-23SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Subjects


US Congress State Sources


Bill Comments

feedback